等待開盤 07-02 09:30:00 美东时间
-1.645
-1.33%
特朗普2025年收入至少达22亿美元,较2024年显著增长。其商业版图涵盖多元资产与海外项目,股票交易超过2.1万笔、日均约80笔,并多次出现在政策与市场关键节点附近。
07-01 13:11
MSC Industrial Direct (MSM) is scheduled to announce Q3 earnings results on Wednesday, July 1th, before market open. The consensus EPS Estimate is $1.26 (+16.7% Y/Y) and the consensus Revenue Estimate...
06-30 22:57
Constellation Brands (STZ) is scheduled to announce Q1 earnings results on Tuesday, June 30th, after market close. The consensus EPS Estimate is $3.21 (-0.3% Y/Y) and the consensus Revenue Estimate is...
06-30 05:35
Nike (NKE) heads into Tuesday's earnings report carrying the accumulated weight of a stock that has fallen nearly 9% since its last quarterly update sent it tumbling in early April. The July 2 options...
06-29 19:17
Naspers ADR press release (NPSNY): FY Non-GAAP EPS of $3.20 beats by $2.26. Revenue of $10.85B (+51.1% Y/Y) beats by $710M. 53% growth in Ecosystem revenue, to US$9.7B. 84% increase in Ecosystem aEBIT...
06-29 16:43
①SpaceX计划下个月开始建造一条8英里长的天然气管道,预计明年1月26日投入使用,为位于德克萨斯州南部的星际基地发射场供气; ②该项目旨在取代目前耗费大量人力的液态甲烷卡车运输方式,为SpaceX公司在扩大星舰(Starship)运营规模时提供更高效的燃料供应。
06-26 10:54
There is a "decent chance" the Federal Reserve will raise interest rates in July, putting the odds at fifty-fifty, according to Lindsay Rosner, Goldman Sachs Asset Management head of multi-sector fixe...
06-24 02:54
Lindsay sets fiscal Q3 earnings call and webcast Lindsay will release fiscal 2026 third-quarter results for the period ended May 31, 2026 before the open on July 2, 2026. Management will host an earnings conference call on July 2, 2026 at 11:00 a.m. ET. Webcast access via https://www.lindsay.com ; t
06-18 18:45
Elite UK REIT launches £7.4 million private placement at £0.30-£0.3 per unit Elite UK REIT launched a fully underwritten private placement to raise about GBP 7.4 million. Offer targets institutional, accredited, and other investors; issue price set at GBP 0.296 to GBP 0.3 per unit. Proceeds earmarke
06-16 08:43
Fennec Pharmaceuticals Inc. granted 10,000 incentive stock options to a new non-executive employee under its 2026 Equity Inducement Plan. The options, exercisable at $9.00 per share, vest over three years and expire in ten years. Fennec focuses on reducing cisplatin-induced ototoxicity in cancer patients with its FDA-approved PEDMARK®. The company has partnered with Norgine to commercialize PEDMARQSI® in Europe and other regions.
06-15 10:00